Michael Hallek, MD from the University of Cologne, Cologne, Germany talks about the issue of drug cost in oncology. According to Prof. Hallek, this is a political problem and an economic burden for society. He argues that politicans, companies, health insurers and patients need to work together proactively anf find a solution to make sure, that combination therapies are affordable everywhere in the world.
Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.
The financial burden of cancer treatment and how to address it
